(NasdaqGM:ENPH), FREMONT, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced an expanded number of utilities have approved the Enphase IQ(R) Meter Collar for behind-the-meter installation. Pacific Gas and Electric Company (PG&E) and San […]

Peptide Therapeutics Market to Reach USD 81.5 Billion by 2034, Driven by Demand for Targeted and Personalized Medicine The global peptide therapeutics market size is calculated at USD 54.57 billion in 2026 and is expected to reach around USD 81.5 billion by 2034, growing at a CAGR of 5.35% for the forecasted period. GlobeNewswire November

Curium Biopharma will continue to lead discovery and new product development Strategic move aims to accelerate biopharma innovation and revolutionize the diagnosis and treatment of cancer Curium International headquarters remain in Paris, France, while the United States headquarters are in St Louis, Missouri ST. LOUIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — Curium, a company dedicated

NextNRG Reports Q3 2025 Revenues Up 232% Year-Over-Year GlobeNewswire November 17, 2025 Record Financial Performance Highlights Expansion of Integrated Energy Platform Across New Markets Operational Execution Drives Gross Profit Margins to 11% MIAMI, Nov. 17, 2025 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, stored,

FundGuard Appoints Industry Veteran Simon Behan as Chief Commercial Officer to Accelerate Global Growth GlobeNewswire November 17, 2025 NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — FundGuard, the cloud-native investment accounting platform transforming how asset owners, managers and asset servicers operate at scale, today are excited to announce the appointment of Simon Behan as Chief

(Other OTC:PETV),(OTC US:PETV),(OTC US:PETVW),(Other OTC:PETVW), Comprehensive Documentation Confirms Production-Ready Architecture for PetVivo's Veterinary Platform Launching Q1 2026 MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), in cooperation with its wholly owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., an emerging biomedical device company focused on commercializing groundbreaking

— Preclinical data with TK-6302 has shown best-in-class anti-tumor efficacy, demonstrating its potential to elicit deep and durable responses in diverse solid tumor indications with high unmet need — Following CTA approval, Phase 1 ATLAS trial planned to begin in 2026 SAN FRANCISCO and BERLIN, Nov. 17, 2025 (GLOBE NEWSWIRE) — T-knife Therapeutics, Inc., a

Celestica Introduces the SD6300 Platform Aiming to Deliver Maximum Storage Density for Enterprise and AI Applications GlobeNewswire November 17, 2025 TORONTO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Celestica Inc. (NYSE: CLS) (TSX: CLS), a global leader in data center infrastructure and advanced technology solutions, today introduced its latest storage platform, the SD6300 ultra-dense storage expansion

HomesToLife Reports 71% Increase in Net Profit to US$13.1 Million for 9M 2025 Export growth and margin improvement drive continued performance GlobeNewswire November 17, 2025 SINGAPORE, Nov. 17, 2025 (GLOBE NEWSWIRE) — HomesToLife Ltd (Nasdaq: HTLM) (“HomesToLife” or the “Company”), a Singapore-based home furniture company with sales across Asia-Pacific, Europe and North America, today announced

(NASDAQ:INDP), NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that Michael Newman, Ph.D., Founder and Chief Scientific Officer, will present at the 3rd Donor Selection & Cell Source Summit, taking